top of page
Search
NeuroTherapia completes enrollment in Phase 1 first-in-human trial of NTRX-07
NeuroTherapia has completed enrollment of its Phase 1 single dose study of NTRX-07 in normal volunteers. Top line data is expected to be...
josephfoss
Jul 6, 20201 min read
691 views
0 comments
NeuroTherapia Initiates First-In-Human Clinical Trials of NTRX-07 For Alzheimer’s Disease
NeuroTherapia, Inc., a Cleveland Clinic spin-off company, has started its first-in-human Phase I clinical trial of NTRX-07, a new drug...
NeuroTherapia News
Oct 31, 20192 min read
769 views
0 comments
NeuroTherapia to Start Clinical Trials of NTRX-07 For Alzheimer’s Disease
CLEVELAND, OH – NeuroTherapia, Inc., a Cleveland Clinic spin-off company, will be starting clinical trials of NTRX-07, a new drug...
NeuroTherapia News
Oct 13, 20192 min read
242 views
0 comments
Alzheimer's Association Supports First Human Trials of NTRX-07
NeuroTherapia has received funding from the Alzheimer's Association to support the first human trials of NTRX-07, a novel new therapy...
NeuroTherapia News
Jun 13, 20191 min read
103 views
$1.7 MILLION ADDF GRANT SUPPORTS PROMISING DRUG THAT TARGETS CANNABINOID RECEPTOR
NeuroTherapia, Inc. has received a $1.7 million commitment from the Alzheimer’s Drug Discovery Foundation (ADDF) to advance its drug...
NeuroTherapia News
Sep 21, 20162 min read
92 views
Cleveland Clinic Spin-Off NeuroTherapia Targets Pain and Alzheimer's Disease
A new Cleveland Clinic spinoff company has raised an initial $1 million to advance the development of a new therapeutic to take on...
NeuroTherapia News
Oct 13, 20151 min read
97 views
Alzheimer's Drug Discovery Foundation Provides NeuroTherapia Funding to Advance Research
Sotheby's in New York City is famous for dealing in works of art and antiques,but at the Alzheimer’s Drug Discovery Foundation’s (ADDF)...
NeuroTherapia News
Apr 27, 20152 min read
73 views
bottom of page